Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residual disease

Tumori

Volumn 85, Issue 4, 1999, Pages 220-228

  Trecate, Giovanna ^a   Ceglia, Errico ^a   Stabile, Fernando ^a   Tesoro Tess, John David ^a   Mariani, Gabriella ^a   Zambetti, Milvia ^a   Musumeci, Renato ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Angiogenetic activity; Dynamic analysis by MRI; Induction chemotherapy; Locally advanced breast carcinoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; NAVELBINE; PACLITAXEL;

ADVANCED CANCER; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

EID: 0032840446     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500402     Document Type: Article

References (40)

1. Abraham D., Jones R., Jones S.: Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer, 78: 91-100, 1996.
2. Aisner J., Morris D., Elias E.G.: Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. Arch. Surg., 117: 882-887, 1982.
3. Blood C.H., Zetter B.R.: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032-1089, 1990.
4. Boets C., Mus R.D., Barentz J.O.: Characterization of suspect breast lesions by using a gadolinium enhanced dynamic turbo-flash subtraction technique. Radiology, 189(P): 301, 1993.
5. Bonadonna G., Veronesi U., Brambilla C.: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J. Natl. Cancer Inst., 82: 1539-1545, 1990.
6. Bonadonna G.: Conceptual and practical advances in the management of breast cancer. J. Clin. Oncol., 7: 1380-1397, 1989.
7. Calais G., Berger C., Descamps P.: Conservative treatment feasibility with induction chemotherapy, surgery and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer, 74: 1283-1288, 1994.
8. Cocconi G., Di Blasio B., Alberti G.: Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res. Treat., 4: 309-313, 1984.
9. Cross M.J., Harms S.E., Cheek J.H.: New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am. J. Surg., 166: 749-755, 1993.
10. Davis P.L., McCarty S.K.: Technologic considerations for breast tumor size assessment. MRI Clin. North. Am., 2: 623-631, 1994.
11. Feldman L.D., Hortobagyi G.N., Buzdar A.U.: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res., 46: 2578-2581, 1986.
12. Fisher B., Anderson S.: Conservative surgery for the management of invasive and non invasive carcinoma of the breast: NSABP trials. World J. Surg., 18: 63-69, 1994.
13. Folkman J., Klagsbrun M.: Angiogenic factors. Science, 235: 442, 1987.
14. Folkman J.: Tumor angiogenesis. Adv. Cancer Res., 43: 175-199, 1985.
15. Gilles R., Guinebretiere J.M., Tardivon A.: Non palpable breast tumors: diagnosis by using dynamic contrast enhanced subtraction MR imaging. Radiology, 89(P): 105, 1993.
16. Gilles R., Guinebretiere J.M., Toussaint C., Spielman M., Rietjens M., Petit J.Y., Contesso G., Masselot J., Vanel D.: Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology, 191: 633-638, 1994.
17. Gilles R., Meunier M., Lucidarme O., Zafrani B., Guinebretiere J.M., Tardivon A., Le Gal M., Vanel D., Neuenschwander S., Arriagada R.: Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J. Comput. Assist. Tomogr., 20: 9-14, 1996.
18. Gimbrone M.A., Leapman S.B., Cotran R.S., Folkman J.: Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 73: 461-473, 1972.
19. Gullino P.M.: Natural history of breast cancer. Cancer, 39: 2697-2703, 1997.
20. Hayes D.F.: Angiogenesis and breast cancer. Hematol. Oncol. Clin. North. Am., 8: 51, 1994.
21. Heywang S., Hahn D., Schmidt H.: MR imaging of the breast using Gd-DTPA. J. Comput. Assist. Tomogr., 10: 199, 1986.
22. Heywang S., Wolf A., Pruss E., Hilbertz T., Eiermann W., Permanetter W.: MR imaging of the breast with Gd-DTPA: use and limitations. Radiology, 171: 95-103, 1989.
23. Heywang-Kobrunner S.: Contrast-enhanced magnetic resonance imaging of the breast. Investigative Radiology, 29: 94-104, 1994.
24. Hortobagy G.N., Blumenschein G.R., Spanos W.: Multimodal treatment of locoregionally advanced breast cancer. Cancer, 51: 76, 1983.
25. Hortobagy G.N., Ames F.C., Buzdar A.U.: Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer, 62: 2507-2516, 1988.
26. Jensen H.M., Chen J., De Vault M.R., Lewis A.E.: Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. Science, 218: 293, 1982.
27. Kaiser W.: False-positive results in dynamic MR mammography. Causes, frequency and methods to avoid. MRI Clin. North Am., 2: 539-555, 1994.
28. Kaiser W., Zeitler E.: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology, 170: 681-686, 1989.
29. Kaiser W.A.: MRM promises earlier breast cancer diagnosis. Diagnostic Imaging International, 11: 44-50, 1992.
30. Knopp M.V., Brix G., Junkermann H.J.: MR-mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. MRI Clin. North Am., 2: 633-658, 1994.
31. Kurtz B., Achten C., Audretsch W.: MR-mammography assessment of tumor response after neoadjuvant radiochemotherapy of locally advanced breast carcinoma. ROFO, 164: 469-474, 1996.
32. Lopez M.J., Andriole D.P., Kraybill W.G.: Multimodal therapy in locally advanced breast carcinoma. Am. J. Surg., 160: 669-675, 1990.
33. Mumtaz H., Davidson T., Spittle M.: Breast surgery after neoadjuvant treatment. Is it necessary? Eur. J. Surg. Oncol., 22: 335-341, 1996.
34. Ottinetti A., Sapino A.: Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res. Treat., 11: 241-248, 1988.
35. Samejima N., Yamazaki K.: A study on the vascular proliferation in tissues around the tumor in breast cancer. Jpn. J. Surg., 18: 235-242, 1988.
36. Schwartz G.F., Birchansky C.A., Komarnicky L.T.: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer, 73: 362-369, 1994.
37. Singletary S.E., McNeese M.D., Hortobagy G.N.: Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer, 69: 2849-2852, 1992.
38. Stack J.P., Redmond O.M., Cobb M.B.: Breast disease. Tissue characterization with Gd-DTPA enhancement profiles. Radiology, 174: 491, 1990.
39. Watt A.C., Ackerman L.V., Windham P.J.P.: Breast lesions: differential diagnosis using digital subtraction angiography. Radiology, 159: 39-42, 1986.
40. Weidmern N., Semple J.P., Welch W.R.: Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.